These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4477555)

  • 1. Cytotoxicity of lymphocytes from patients with cancer of the urinary bladder: detection by a 3-H-proline microcytotoxicity test.
    Bean MA; Pees H; FOGH JE; Grabstald H; Oettgen HF
    Int J Cancer; 1974 Aug; 14(2):186-97. PubMed ID: 4477555
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphocyte antibody interaction in cytotoxicity against human transitional cell carcinoma.
    Hakala TR; Lange PH; Castro AE; Elliott AY; Fraley EE
    J Urol; 1975 May; 113(5):663-7. PubMed ID: 1168732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-mediated cytotoxicity against human bladder cancer.
    Bloom ET; Ossorio RC; Brosman SA
    Int J Cancer; 1974 Sep; 14(3):326-34. PubMed ID: 4477556
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibody induction of lymphocyte-mediated cytotoxicity against human transitional-cell carcinomas of the urinary tract.
    Hakala TR; Lange PH; Castro AE; Elliott AY; Fraley EE
    N Engl J Med; 1974 Sep; 291(13):637-41. PubMed ID: 4859212
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro cytotoxicity studies in bladder and renal cell cancer.
    Elhilali MM; Nayak SK
    Urology; 1976 May; 7(5):488-91. PubMed ID: 1274005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic features of genitourinary cancer.
    Javadpour N
    Urology; 1973 Aug; 2(2):103-8. PubMed ID: 4129366
    [No Abstract]   [Full Text] [Related]  

  • 7. Cell mediated cytotoxicity against human transitional cell carcinomas of the genitourinary tract.
    Hakala TR; Lange PH; Castro A; Elliott A; Fraley EE
    Cancer; 1974 Dec; 34(6):1929-34. PubMed ID: 4434325
    [No Abstract]   [Full Text] [Related]  

  • 8. Transitional cell and renal carcinoma: cell-mediated immunity as determined by the lymphocyte titration technique.
    Hakala TR
    Natl Cancer Inst Monogr; 1978 Dec; (49):151-2. PubMed ID: 571043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte-mediated cytotoxicity in patients with renal and transitional cell carcinoma receiving BCG.
    Lange PH
    Natl Cancer Inst Monogr; 1978 Dec; (49):343-5. PubMed ID: 748791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum induced lymphoid cell mediated cytotoxicity to human transitional cell carcinomas of the genitourinary tract.
    Hakala TR; Lange PH
    Science; 1974 May; 184(4138):795-7. PubMed ID: 4856602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunobiology of genitourinary tumors.
    Lange PH; Hakala TR; Fraley EE
    Urology; 1973 Nov; 2(5):485-92. PubMed ID: 4358375
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro augmentation of cytotoxicity against tumor cell lines by mumps virus.
    Morales A; Ottenhof P; Elliott M
    Invest Urol; 1980 Jan; 17(4):284-7. PubMed ID: 6927978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prelabeling target cells with 3 H-proline as a method for studying lymphocyte cytotoxicity.
    Bean MA; Pees H; Rosen G; Oettgen HF
    Natl Cancer Inst Monogr; 1973 Jun; 37():41-8. PubMed ID: 4713785
    [No Abstract]   [Full Text] [Related]  

  • 14. Abnormalities of cell-mediated immunocompetence in genitourinary cancer.
    Catalona WJ; Chretien PB; Trahan EE
    J Urol; 1974 Feb; 111(2):229-32. PubMed ID: 4855735
    [No Abstract]   [Full Text] [Related]  

  • 15. Carcinoembryonic antigen in patients with urologic cancers.
    Guinan P; Ablin RJ; Barakat H; John T; Sadoughi N; Bush IM
    Urol Res; 1973 Oct; 1(3):101-5. PubMed ID: 4804082
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro generation of cytotoxic lymphocytes by tumor extracts of transitional cell carcinoma.
    Morales A
    Natl Cancer Inst Monogr; 1978 Dec; (49):173-4. PubMed ID: 748769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective monocyte chemotactic response in genitourinary carcinoma.
    Brosman S; Hausman MS
    Urology; 1974 Aug; 4(2):129-34. PubMed ID: 4851277
    [No Abstract]   [Full Text] [Related]  

  • 18. Specificity of in vitro cellular cytotoxicity against transitional cell carcinoma cell line T-24.
    Catalona WJ; Oldham RK; Djeu JY; Herberman RB; Cannon GB
    Surg Forum; 1975; 26():122-4. PubMed ID: 56048
    [No Abstract]   [Full Text] [Related]  

  • 19. A modification of the (75Se) selenomethionine assay for the detection of complement-dependent antibody in human tumor systems.
    Avis IL; Avis FP
    J Surg Oncol; 1983 Apr; 22(4):231-5. PubMed ID: 6834843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte cytotoxicity in bladder cancer. No requirement for thymus-derived effector cells?
    O'Toole C; Perlmann P; Wigzell H; Unsgaard B; Zetterlund CG
    Lancet; 1973 May; 1(7812):1085-8. PubMed ID: 4123535
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.